SCHEMBL19377352

SCHEMBL19377352

COc1ccc(C(C)NC(=O)Nc2ccc(S(=O)(=O)Nc3ccc4c(c3)CCCN4)cc2)c(Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 7/20 0.41
▸ HTT P42858 3/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ ALDH1A1 P00352 6/20 0.40
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ AVPR2 P30518 1/20 0.39
▸ GPR27 Q9NS67 1/20 0.39
▸ THRB P10828 2/20 0.38
▸ HDAC3 O15379 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC10 Q969S8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377350 1.00 LMNA (0.41) LMNAHTTMAPK1ALOX15SMN1; SMN2
SCHEMBL19377228 0.86 PCTP (0.40) LMNASMN1; SMN2L3MBTL1ALDH1A1NAMPT
SCHEMBL19377230 0.86 PCTP (0.40) LMNASMN1; SMN2L3MBTL1ALDH1A1NAMPT
SCHEMBL19377509 0.85 PNMT (0.43) LMNAHTTMAPK1ALOX15SMN1; SMN2
SCHEMBL19377510 0.85 PNMT (0.43) LMNAHTTMAPK1ALOX15SMN1; SMN2
SCHEMBL19378057 0.83 GHSR (0.41) LMNAHTTMAPK1ALOX15SMN1; SMN2
SCHEMBL19377098 0.81 DRD2 (0.49) LMNAHTTMAPK1ALOX15SMN1; SMN2
SCHEMBL19377102 0.81 DRD2 (0.49) LMNAHTTMAPK1ALOX15SMN1; SMN2
SCHEMBL19377106 0.80 GPR27 (0.56) LMNASMN1; SMN2ALDH1A1AVPR2GPR27
SCHEMBL19377323 0.80 ALDH1A1 (0.51) LMNAHTTMAPK1ALOX15SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR LMNA 3798/4885HTT 696/4885MAPK1 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback